Patients referred via a specialized screening clinic that expedites rheumatoid arthritis diagnosis have lower functional disability than those referred via standard referral pathways.
Violin MD on MSN
A doctor reveals what rheumatoid arthritis does to your bones - "The inflammation actually eats away at the bone"
Inside a rheumatology clinic, doctors investigate patients with severe joint inflammation and rheumatoid arthritis. One ...
Immunotherapies such as CAR T-cell therapy are used primarily to treat cancer. In the future, these patient-specific ...
Spyre's SPY072 shows activity in RA, but a smaller-than-expected benefit shifts its focus toward broader autoimmune uses and ...
Immunotherapies such as CAR T-cell therapy are used primarily to treat cancer. In the future, these patient-specific ...
A year after approval of the first VNS device for rheumatoid arthritis, many patients are interested and providers in eight ...
Discover why venous thromboembolism in rheumatoid arthritis remains elevated despite remission. Read more about the latest ...
Phase 2 data on Spyre Therapeutics’ anti-TL1A antibody SPY072 in rheumatoid arthritis have fallen short of expectations, ...
The results erased more than $1 billion in market value and raised questions about how impactful drugs that block the TL1A ...
Upadacitinib is a medication widely used for the treatment of rheumatoid arthritis that works by inhibiting Janus kinase (JAK ...
Spyre Therapeutics’ hopes for its anti-TL1A antibody SPY072 in rheumatoid arthritis (RA) have hit a bump in the road after ...
USA-based biotech Spyre Therapeutics will not advance its experimental antibody SPY072 as a stand-alone treatment for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results